Evaluation of FHIT gene alterations in ovarian cancer
Author Information
Author(s): F Buttitta, A Marchetti, O Radil, G Bertaccal, S Pellegrinil, A Gadducci, AR Genazzani, G Bevilacqual
Primary Institution: University of Pisa
Hypothesis
We decided to investigate the role of FHIT in human ovarian tumorigenesis.
Conclusion
The results indicate that FHIT plays a role in a small proportion of ovarian carcinomas.
Supporting Evidence
- An abnormal transcript of the FHIT gene was found in two cases (4%) and allelic losses in eight cases (15%).
- Twelve (22%) of the 54 tumours investigated belonged to young patients with a family history of breast/ovarian cancer.
- Only samples with a high proportion of neoplastic cells were subjected to genetic analysis.
Takeaway
This study looked at a gene called FHIT in ovarian cancer and found that it is only changed in a few cases.
Methodology
Fifty-four primary ovarian carcinomas were studied using reverse transcription of FHIT mRNA followed by PCR amplification and sequencing.
Limitations
The number of cases with FHIT aberrations is too low to draw definitive conclusions.
Participant Demographics
The study included 54 patients, with 42 post-menopausal and 12 young patients with a family history of breast/ovarian cancer.
Want to read the original?
Access the complete publication on the publisher's website